- Home
- LXU vs ARVN Comparison
LXU vs ARVN Comparison
Compare LXU & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXU
- ARVN
- Stock Information
- Founded
- LXU 1968
- ARVN 2015
- Country
- LXU United States
- ARVN United States
- Employees
- LXU N/A
- ARVN N/A
- Industry
- LXU Major Chemicals
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- LXU Industrials
- ARVN Health Care
- Exchange
- LXU Nasdaq
- ARVN Nasdaq
- Market Cap
- LXU 612.4M
- ARVN 676.2M
- IPO Year
- LXU 1969
- ARVN 2018
- Fundamental
- Price
- LXU $9.73
- ARVN $10.59
- Analyst Decision
- LXU Buy
- ARVN Buy
- Analyst Count
- LXU 3
- ARVN 23
- Target Price
- LXU $10.17
- ARVN $17.80
- AVG Volume (30 Days)
- LXU 442.0K
- ARVN 2.3M
- Earning Date
- LXU 10-29-2025
- ARVN 11-05-2025
- Dividend Yield
- LXU N/A
- ARVN N/A
- EPS Growth
- LXU N/A
- ARVN N/A
- EPS
- LXU N/A
- ARVN N/A
- Revenue
- LXU $585,065,000.00
- ARVN $312,300,000.00
- Revenue This Year
- LXU $14.21
- ARVN N/A
- Revenue Next Year
- LXU $0.20
- ARVN N/A
- P/E Ratio
- LXU N/A
- ARVN N/A
- Revenue Growth
- LXU 12.49
- ARVN 93.86
- 52 Week Low
- LXU $4.88
- ARVN $5.90
- 52 Week High
- LXU $9.98
- ARVN $27.00
- Technical
- Relative Strength Index (RSI)
- LXU 62.33
- ARVN 59.44
- Support Level
- LXU $8.20
- ARVN $9.27
- Resistance Level
- LXU $9.85
- ARVN $11.51
- Average True Range (ATR)
- LXU 0.48
- ARVN 0.53
- MACD
- LXU 0.11
- ARVN 0.02
- Stochastic Oscillator
- LXU 86.56
- ARVN 59.15
About LXU LSB Industries Inc.
LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.